Oncotarget
PRL-3 chimeric mAb recognizes EGFP-PRL-3 overexpressed in DLD-1 human colorectal cancer cells by indirect immunofluorescence. Shown is the composite image of EGFP-PRL-3 in fixed DLD-1 cells (green) and PRL-3 chimeric antibody together with an image of anti-human IgG Texas-Red (red) to reveal the binding to PRL-3 protein. See Guo et al.
c-MYC and SIRT1 locked in a vicious cycle |
https://doi.org/10.18632/oncotarget.440 Antje Menssen, and Heiko Hermeking |
112-113 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Modulating Mesothelin Shedding to Improve Therapy |
https://doi.org/10.18632/oncotarget.445 Ira Pastan, and Yujian Zhang |
114-115 |
PDF | HTML | How to cite | Order a Reprint |
Bryostatin analog: improving on Nature’s design |
https://doi.org/10.18632/oncotarget.460 Dale Boger |
116-117 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Targeting Mnks for Cancer Therapy |
https://doi.org/10.18632/oncotarget.453 Jinqiang Hou, Frankie Kam, Christopher G Proud, and Shudong Wang |
118-131 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63. |
https://doi.org/10.18632/oncotarget.447 Elena Martynova, Silvia Pozzi, Valentina Basile, Diletta Dolfini, Federico Zambelli, Carol Imbriano, Giulio Pavesi, and Roberto Mantovani |
132-143 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Ras inhibition by FTS attenuates brain tumor growth in mice directly and by enhancing reactivity of cytotoxic lymphocytes |
https://doi.org/10.18632/oncotarget.420 Elizabeta Aizman, Adi Mor, Ayelet Levy, Jacob George, and Yoel Kloog |
144-157 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice |
https://doi.org/10.18632/oncotarget.442 Ke Guo, Jing Ping Tang, Jie Li, Cheng Peow Tan, Abdul Qader O. Al-Aidaroos, Cheng William Hong, Leyon Varghese, Zhi Wei Feng, Jung Eun Park, Jian Biao Zhou, Wee Joo Chng, and Qi Zeng |
158-171 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1 |
https://doi.org/10.18632/oncotarget.454 Julie S. Barber-Rotenberg, Saravana P. Selvanathan, Yali Kong, Hayriye V. Erkizan, Tara M. Snyder, S. Peter Hong, Christina L. Kobs, Natalie L. South, Steven Summer, Philip J. Monroe, Maksymilian Chruszcz, Veselin Dobrev, Perrer N. Tosso, Lauren J. Scher, Wladek Minor, Milton L. Brown, Steven J. Metallo, Aykut Üren, and Jeffrey A. Toretsky |
172-182 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor |
https://doi.org/10.18632/oncotarget.449 Natalya V. Guseva, Oskar W. Rokhlin, Thomas B. Bair, Rebecca B. Glover, and Michael B. Cohen |
183-194 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia |
https://doi.org/10.18632/oncotarget.448 Carlo Maria Croce, Rosa Visone, Angelo Veronese, and Veronica Balatti |
195-202 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Novel targeted therapies for mantle cell lymphoma |
https://doi.org/10.18632/oncotarget.426 Lapo Alinari, Beth Christian, and Robert Baiocchi |
203-211 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
A Gene Expression Profile Test for the Differential Diagnosis of Ovarian Versus Endometrial Cancers |
https://doi.org/10.18632/oncotarget.450 Anita Lal, Rebecca Panos, Mira Marjanovic, Michael Walker, Eloisa Fuentes, Daniel S. Kapp, W David Henner, Ljubomir J. Buturovic, and Meredith Halks-Miller |
212-223 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC